At the end of March, hedge funds had collectively built up
concentrated positions in a select group of U.S. stocks, with
Boston Scientific and Sprint Nextel emerging as favorites,
according to new research by Goldman Sachs.
Goldman's analysis of recent filings with the U.S.
Securities and Exchange Commission also found that at the end
of the first quarter, hedge fund portfolios were tilted toward
smaller companies and consumer discretionary stocks, while
portfolios were "dramatically underweight" on financials...